162 related articles for article (PubMed ID: 35921211)
1. Influence of PD-1/PD-L1 on immune microenvironment in oral leukoplakia and oral squamous cell carcinoma.
Xu SB; Wang MY; Shi XZ; Wang Q; Yu M; Zhang W; Xu XH; Liu LK
Oral Dis; 2023 Nov; 29(8):3268-3277. PubMed ID: 35921211
[TBL] [Abstract][Full Text] [Related]
2. Expression of programmed cell death-ligand 1 in oral squamous cell carcinoma and oral leukoplakia is associated with disease progress and CD8+ tumor-infiltrating lymphocytes.
Chen XJ; Tan YQ; Zhang N; He MJ; Zhou G
Pathol Res Pract; 2019 Jun; 215(6):152418. PubMed ID: 31027907
[TBL] [Abstract][Full Text] [Related]
3. CD8+ and CD163+ infiltrating cells and PD-L1 immunoexpression in oral leukoplakia and oral carcinoma.
Stasikowska-Kanicka O; WÄ…growska-Danilewicz M; Danilewicz M
APMIS; 2018 Sep; 126(9):732-738. PubMed ID: 30160018
[TBL] [Abstract][Full Text] [Related]
4. Correlation of PD-1 and PD-L1 expression in oral leukoplakia and oral squamous cell carcinoma: an immunohistochemical study.
Greeshma LR; Joseph AP; Sivakumar TT; Raghavan Pillai V; Vijayakumar G
Sci Rep; 2023 Dec; 13(1):21698. PubMed ID: 38066025
[TBL] [Abstract][Full Text] [Related]
5. PD-1/PD-L1, Treg-related proteins, and tumour-infiltrating lymphocytes are associated with the development of oral squamous cell carcinoma.
Kujan O; Agag M; Smaga M; Vaishnaw Y; Idrees M; Shearston K; Farah CS
Pathology; 2022 Jun; 54(4):409-416. PubMed ID: 34872754
[TBL] [Abstract][Full Text] [Related]
6. Copy Number Alterations Predict Development of OSCC from Oral Leukoplakia.
Cai X; Zhang J; Li L; Liu L; Tang M; Zhou X; Peng C; Li X; Chen X; Xu M; Zhang H; Wang J; Huang Y; Li T
J Dent Res; 2024 Feb; 103(2):138-146. PubMed ID: 38217281
[TBL] [Abstract][Full Text] [Related]
7. Development of a Pathomics-Based Model for the Prediction of Malignant Transformation in Oral Leukoplakia.
Cai X; Li L; Yu F; Guo R; Zhou X; Zhang F; Zhang H; Zhang J; Li T
Lab Invest; 2023 Aug; 103(8):100173. PubMed ID: 37164265
[TBL] [Abstract][Full Text] [Related]
8. Expression of FAP in Oral Leukoplakia and Oral Squamous Cell Carcinoma.
Li R; Zhang R; Shi X; Jiao X; Li Y; Zhao Y; Liu T; Zhang C
Int Dent J; 2024 Jun; 74(3):581-588. PubMed ID: 38278714
[TBL] [Abstract][Full Text] [Related]
9. DEC1: a potential biomarker of malignant transformation in oral leukoplakia.
Mao T; Xiong H; Hu X; Hu Y; Wang C; Yang L; Huang D; Xia K; Su T
Braz Oral Res; 2020; 34():e052. PubMed ID: 32578762
[TBL] [Abstract][Full Text] [Related]
10. Mesenchymal stem cell-exosome-mediated matrix metalloproteinase 1 participates in oral leukoplakia and carcinogenesis by inducing angiogenesis.
Li S; Han Y; Lu M; Liu Z; Jin J; Guo Q; Wang Y; Liu H
J Oral Pathol Med; 2022 Aug; 51(7):638-648. PubMed ID: 35792829
[TBL] [Abstract][Full Text] [Related]
11. Expressions of Interleukin-27 in Oral Lichen Planus, Oral Leukoplakia, and Oral Squamous Cell Carcinoma.
Wang QM; Huang XY; Guan WQ
Inflammation; 2022 Jun; 45(3):1023-1038. PubMed ID: 35064378
[TBL] [Abstract][Full Text] [Related]
12. [Determination of human papillomavirus in oral leukoplakia,oral lichen planus and oral squamous cell carcinoma].
Cao J; Jin JQ; Deng DJ; Liu HW
Beijing Da Xue Xue Bao Yi Xue Ban; 2016 Feb; 48(1):84-8. PubMed ID: 26885914
[TBL] [Abstract][Full Text] [Related]
13. Identification of a Favorable Prognostic Subgroup in Oral Squamous Cell Carcinoma: Characterization of ITGB4/PD-L1
Ma SR; Liu JF; Jia R; Deng WW; Jia J
Biomolecules; 2023 Jun; 13(6):. PubMed ID: 37371594
[TBL] [Abstract][Full Text] [Related]
14. Compositional and functional changes in the salivary microbiota related to oral leukoplakia and oral squamous cell carcinoma: a case control study.
Lan Q; Zhang C; Hua H; Hu X
BMC Oral Health; 2023 Dec; 23(1):1021. PubMed ID: 38115005
[TBL] [Abstract][Full Text] [Related]
15. The CXCL11-CXCR3A axis influences the infiltration of CD274 and IDO1 in oral squamous cell carcinoma.
Wang X; Zhang J; Zhou G
J Oral Pathol Med; 2021 Apr; 50(4):362-370. PubMed ID: 33187013
[TBL] [Abstract][Full Text] [Related]
16. Clinical and Biological Significance of PD-L1 Expression Within the Tumor Microenvironment of Oral Squamous Cell Carcinoma.
Takahashi H; Sakakura K; Arisaka Y; Tokue A; Kaira K; Tada H; Higuchi T; Okamoto A; Tsushima Y; Chikamatsu K
Anticancer Res; 2019 Jun; 39(6):3039-3046. PubMed ID: 31177146
[TBL] [Abstract][Full Text] [Related]
17. PD-1 blockade prevents the progression of oral carcinogenesis.
Dong Y; Wang Z; Mao F; Cai L; Dan H; Jiang L; Zeng X; Li T; Zhou Y; Chen Q
Carcinogenesis; 2021 Jun; 42(6):891-902. PubMed ID: 33993220
[TBL] [Abstract][Full Text] [Related]
18. Comparison of PD-L1 Expression in Oral Squamous Cell Carcinoma and Premalignant Lesions of Oral Cavity.
Saeed S; Rauf F; Iqbal F; Khan AS; Khan AH; Alamgeer R
Asian Pac J Cancer Prev; 2022 Dec; 23(12):4039-4045. PubMed ID: 36579984
[TBL] [Abstract][Full Text] [Related]
19. Immunosuppression Induced by Chronic Inflammation and the Progression to Oral Squamous Cell Carcinoma.
Sun Y; Liu N; Guan X; Wu H; Sun Z; Zeng H
Mediators Inflamm; 2016; 2016():5715719. PubMed ID: 28053372
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value and clinicopathological status of PD-L1 expression and CD8+ TILs in oral squamous cell cancer patients with or without traditional risk factors.
Soopanit T; Laokulrath N; Chayopasakul V; Pongsapich W
Head Neck; 2023 Apr; 45(4):1017-1025. PubMed ID: 36811208
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]